Company Filing History:
2 out of 2,928 
1 out of 1,732 
Years Active: 2016-2023
Title: Innovations by Desmond A Schatz
Introduction
Desmond A Schatz is a notable inventor based in Gainesville, Florida. He has made significant contributions to the field of diabetes research, particularly in the diagnosis and prevention of Type 1 diabetes (T1D). With a total of two patents to his name, his work has the potential to impact the lives of many individuals at risk of developing this condition.
Latest Patents
One of Schatz's latest patents focuses on methods for the diagnosis of Type 1 diabetes. This patent identifies seventeen antigens as potential biomarkers for early detection and risk prediction of T1D. The antigens include MLH1, MTIF3, PPIL2, NUP50, TOX4, FIGN, C9orf142, ZNF280D, HES1, QRFPR, CTRC, SNX6, SYTL4, ELA2A, IGRP, PAX6, and HMGN3. Another patent involves isolated strains that are useful in preventing or delaying the development of T1D. This probiotic composition comprises these strains and offers a promising approach to T1D prevention.
Career Highlights
Desmond A Schatz has worked with reputable institutions, including the University of Florida Research Foundation and Arizona State University. His research has contributed to a deeper understanding of Type 1 diabetes and its biomarkers.
Collaborations
Some of his notable coworkers include Mark A Atkinson and Josef Neu, who have collaborated with him on various research projects.
Conclusion
Desmond A Schatz's innovative work in diabetes research highlights the importance of early diagnosis and prevention strategies for Type 1 diabetes. His contributions through patents and collaborations continue to pave the way for advancements in this critical area of health.